Your browser doesn't support javascript.
loading
Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data.
Hopkins, Ashley M; Van Dyk, Madele; Rowland, Andrew; Sorich, Michael J.
Afiliação
  • Hopkins AM; Flinders Centre for Innovation in Cancer & Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Van Dyk M; Flinders Centre for Innovation in Cancer & Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Rowland A; Flinders Centre for Innovation in Cancer & Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Sorich MJ; Flinders Centre for Innovation in Cancer & Department of Clinical Pharmacology, College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Pigment Cell Melanoma Res ; 32(4): 576-583, 2019 07.
Article em En | MEDLINE | ID: mdl-30758912
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Azetidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Ensaios Clínicos como Assunto / Vemurafenib / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Azetidinas / Protocolos de Quimioterapia Combinada Antineoplásica / Ensaios Clínicos como Assunto / Vemurafenib / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article